170 related articles for article (PubMed ID: 27132167)
1. Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo.
Liu T; Yuan X; Jia T; Liu C; Ni Z; Qin Z; Yuan Y
Int J Pharm; 2016 Jun; 506(1-2):382-93. PubMed ID: 27132167
[TBL] [Abstract][Full Text] [Related]
2. Increasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrug.
Shi XJ; Qiu YY; Yu H; Liu C; Yuan YX; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2018 Jun; 166():224-234. PubMed ID: 29602078
[TBL] [Abstract][Full Text] [Related]
3. Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.
Liu T; Jia T; Yuan X; Liu C; Sun J; Ni Z; Xu J; Wang X; Yuan Y
Int J Nanomedicine; 2016; 11():2235-50. PubMed ID: 27284243
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract][Full Text] [Related]
5. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
Li M; Liang Z; Sun X; Gong T; Zhang Z
PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
[TBL] [Abstract][Full Text] [Related]
6. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9.
Li Y; Ye C; Cai C; Zhao M; Han N; Liu Z; Zhai J; Yin J
Pharm Res; 2020 Mar; 37(3):66. PubMed ID: 32166420
[TBL] [Abstract][Full Text] [Related]
8. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
[TBL] [Abstract][Full Text] [Related]
9. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
[TBL] [Abstract][Full Text] [Related]
10. Polymeric micelles for parenteral delivery of sagopilone: physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo.
Richter A; Olbrich C; Krause M; Hoffmann J; Kissel T
Eur J Pharm Biopharm; 2010 Jun; 75(2):80-9. PubMed ID: 20188169
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
12. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
Lukyanov AN; Torchilin VP
Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
[TBL] [Abstract][Full Text] [Related]
13. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
Zhao YJ; Wei W; Su ZG; Ma GH
Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.
Yousefi G; Foroutan SM; Zarghi A; Shafaati A
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):147-53. PubMed ID: 20118571
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin.
Podaralla S; Averineni R; Alqahtani M; Perumal O
Mol Pharm; 2012 Sep; 9(9):2778-86. PubMed ID: 22770552
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates.
Shen J; Zhang D; Zhao Z; Jia L; Zheng D; Liu G; Hao L; Zhang Q; Tian X; Li C; Guo H
Int J Pharm; 2013 Nov; 456(1):80-6. PubMed ID: 23973480
[TBL] [Abstract][Full Text] [Related]
18. In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Li Y; Angelova A; Liu J; Garamus VM; Li N; Drechsler M; Gong Y; Zou A
Colloids Surf B Biointerfaces; 2019 Jan; 173():217-225. PubMed ID: 30296646
[TBL] [Abstract][Full Text] [Related]
19. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.
Lee SC; Huh KM; Lee J; Cho YW; Galinsky RE; Park K
Biomacromolecules; 2007 Jan; 8(1):202-8. PubMed ID: 17206808
[TBL] [Abstract][Full Text] [Related]
20. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]